RT @AmineKorchiMD: The accuracy of #DTC tests has come into question. Tandy-Connor et al. performed follow-up sequencing in a clinical mole…
This case illustrates a real-life example of potential harm from DTC #genetic testing. #23andme https://t.co/AVgA6oJLmT
RT @KylaDunn5: Despite pre- and post-test genetic counseling for Myriad test, and reading 23andMe website caveats, this BRCA2+ patient stil…
Despite pre- and post-test genetic counseling for Myriad test, and reading 23andMe website caveats, this BRCA2+ patient still needs more: “When you have a moment, can you explain (in more scientifically specific terms), why my Myriad test came back positiv
"In the field of genetics, the potential for harm is very real, but typically does not result in an acute event such as an adverse medication reaction or a surgical complication." Thanks for the case report and thoughtful commentary on DTC genetic testing
First do no harm, GIM article on DTC testing: https://t.co/R5ZlfYDSwN @katie_stoll @KylaDunn5
RT @talastal: First, do no harm: direct-to-consumer genetic testing | Genetics in Medicine #consumergenetics #Genetics https://t.co/FOqsea…
RT @BpGenetics: Not all #genetic tests are created equal. Senior Geneticist at Blueprint Genetics, Jennifer Schleit, was recently published…
RT @talastal: First, do no harm: direct-to-consumer genetic testing | Genetics in Medicine #consumergenetics #Genetics https://t.co/FOqsea…
RT @talastal: First, do no harm: direct-to-consumer genetic testing | Genetics in Medicine #consumergenetics #Genetics https://t.co/FOqsea…
Not all #genetic tests are created equal. Senior Geneticist at Blueprint Genetics, Jennifer Schleit, was recently published in @GIMJournal regarding the implications for patients of direct-to-consumer genetic testing. Learn more here: https://t.co/YiRHTpOv
First, do no harm: direct-to-consumer genetic testing | Genetics in Medicine #consumergenetics #Genetics https://t.co/FOqseafZrQ